Publications

5538 Results

A randomized study of alpha-interferon consolidation in patients with low-grade lymphoma who have responded to pro-MACE-MOPP (day 1-8) (SWOG 8809).

Authors
BW Dana;J Unger;RI Fisher
Journal / Conference
Proc of the American Society of Clinical Oncology 17:3a(#10)
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809

Chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: Progress report.

Authors
M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley
Journal / Conference
Proc of the American Society of Clinical Oncology 17:385a(#1483)
Year
1998
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

CMF versus CAF with and without tamoxifen in high-risk node-negative breast cancer patients and a natural history follow-up study in low-risk node-negative patients: First results of intergroup trial INT 0102.

Authors
L Hutchins;S Green;P Ravdin;D Lew;S Martino;M Abeloff;A Lyss;C Henderson;C Allred;S Dakhil;I Pierce;W Goodwin;J Caton;S Rivkin;R Chapman;K Osborne
Journal / Conference
Proc of the American Society of Clinical Oncology 17:1a(#2)
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-8897

Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma (SWOG 9212).

Authors
EA Poplin;PY Liu;J Delmore;S Wilczynski;D Alberts
Journal / Conference
Proc of the American Society of Clinical Oncology 17:373a(#1436)
Year
1998
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9212

Randomized phase 3 study of intravenous (IV) cisplatin (CIS)/paclitaxel (PAC) versus moderately high dose IV carboplatin (CARB) followed by IV PAC and intraperitoneal (IP) CIS in optimal residual ovarian cancer (OC): An intergroup trial (GOG, SWOG, ECOG).

Authors
M Markman;B Bundy;J Benda;D Alberts;S Wadler;J Fowler;D Clark-Pearson;LF Carson
Journal / Conference
Proc of the American Society of Clinical Oncology 17:361a(#1392)
Year
1998
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9227 (GOG-114)

Docetaxel (taxotere) in extensive stage small cell lung cancer (SCLC): A phase II trial of the Southwest Oncology Group (SWOG).

Authors
HA Burris;JJ Crowley;SK Williamson;DR Gandara;RB Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 17:451a(#1737)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9242

Randomized phase III trial of cisplatin (CDDP) vs CDDP plus navelbine (NVB) in treatment of advanced non-small cell lung cancer (NSCLC): An update of a Southwest Oncology Group study (SWOG 9308).

Authors
AJ Wozniak;JJ Crowley;SP Balcerzak;GR Weiss;CH Spiridonidis;LH Baker;KS Albain;K Kelly;SA Taylor;DR Gandara;RB Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 17:453a(#1744)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9308

Androgen deprivation (AD) + 4-courses of fixed-schedule suramin in D2 prostate cancer (PCA) patients (pts): A Southwest Oncology Group phase II study.

Authors
M Hussain;E Fisher;D Wood;E Small;M Eisenberger;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 17:314a(#1211)
Year
1998
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9343

Analysis of suramin (S) levels obtained from D2 hormone naive prostate cancer (HNPCA) patients (pts) treated with fixed bolus suramin: A Southwest Oncology Group study.

Authors
DP Petrylak;JO Connor;E Fisher;M Eisenberger;ED Crawford;M Hussain
Journal / Conference
Proc of the American Society of Clinical Oncology 17:340a(#1310)
Year
1998
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9343

Initial report of the SWOG biological correlative study of C-ERBB-2 expression as a predictor of outcome in a trial comparing adjuvant CAF T with tamoxifen (T) alone.

Authors
PM Ravdin;S Green;KS Albain;V Boucher;J Ingle;K Pritchard;L Shepard;N Davidson;DF Hayes;GM Clark;S Martino;CK Osborne;DC Allred
Journal / Conference
Proc of the American Society of Clinical Oncology 17:97a(#374)
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9445